Export 549 results:
Author Title [ Type(Asc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
N. Jacobs and Theunissen, B., It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?, J Alzheimers Dis, vol. 90, no. 4, pp. 1401-1415, 2022.
S. - Y. Huang, Yang, Y. - X., Zhang, Y. - R., Kuo, K., Li, H. - Q., Shen, X. - N., Chen, S. - D., Chen, K. - L., Dong, Q., Tan, L., and Yu, J. - T., Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study., J Alzheimers Dis, vol. 87, no. 1, pp. 463-477, 2022.
J. Ning, Huang, S. - Y., Chen, S. - D., Zhang, Y. - R., Huang, Y. - Y., and Yu, J. - T., Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study., J Alzheimers Dis, vol. 87, no. 1, pp. 211-222, 2022.
X. - L. Ding, Tuo, Q. - Z., and Lei, P., An Introduction to Ultrasensitive Assays for Plasma Tau Detection., J Alzheimers Dis, vol. 80, no. 4, pp. 1353-1362, 2021.
G. Lou, Zhang, Q., Xiao, F., Xiang, Q., Su, Z., and Huang, Y., Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 985-90, 2016.
L. Falsetti, Viticchi, G., Buratti, L., Grigioni, F., Capucci, A., and Silvestrini, M., Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study., J Alzheimers Dis, vol. 62, no. 2, pp. 713-725, 2018.
A. Ticinesi, Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Del Rio, D., Ventura, M., Sgoifo, A., and Angelino, D., Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers., J Alzheimers Dis, vol. 86, no. 3, pp. 961-982, 2022.
H. Lövheim, Olsson, J., Weidung, B., Johansson, A., Eriksson, S., Hallmans, G., and Elgh, F., Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer's Disease Development., J Alzheimers Dis, vol. 61, no. 3, pp. 939-945, 2018.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function., J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
B. Zhang, Gaiteri, C., Bodea, L. - G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., Fluder, E., Clurman, B., Melquist, S., Narayanan, M., Suver, C., Shah, H., Mahajan, M., Gillis, T., Mysore, J., MacDonald, M. E., Lamb, J. R., Bennett, D. A., Molony, C., Stone, D. J., Gudnason, V., Myers, A. J., Schadt, E. E., Neumann, H., Zhu, J., and Emilsson, V., Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease., Cell, vol. 153, no. 3, pp. 707-20, 2013.
W. - X. Li, Dai, S. - X., Liu, J. - Q., Wang, Q., Li, G. - H., and Huang, J. - F., Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learning and Memory., J Alzheimers Dis, vol. 51, no. 2, pp. 417-25, 2016.
K. Rajah Kumaran, Yunusa, S., Perimal, E., Wahab, H., Müller, C. P., and Hassan, Z., Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective., J Alzheimers Dis, vol. 91, no. 2, pp. 507-530, 2023.
K. Krishna, Behnisch, T., and Sajikumar, S., Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons., J Alzheimers Dis, vol. 51, no. 3, pp. 783-91, 2016.
A. José Gabriel, Almeida, M. Rosário, Ribeiro, M. Helena, Carneiro, D., Valério, D., Pinheiro, A. Cristina, Pascoal, R., Santana, I., and Baldeiras, I., Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 1097-1105, 2018.
Z. P. Qureshi, Thiel, E., Nelson, J., and Khandker, R., Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients., J Alzheimers Dis, vol. 83, no. 4, pp. 1679-1690, 2021.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau., J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
X. Cao, Zhu, M., He, Y., Chu, W., Du, Y., and Du, H., Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.
L. Pasquini, Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., Wohlschläger, A. M., Riedl, V., and Sorg, C., Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 51, no. 1, pp. 313-26, 2016.
B. M. Law, Guest, A. L., Pullen, M. W. J., Perkinton, M. S., and Williams, R. J., Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay., J Alzheimers Dis, vol. 61, no. 2, pp. 673-688, 2018.
D. Fang, Zhang, Z., Li, H., Yu, Q., Douglas, J. T., Bratasz, A., Kuppusamy, P., and Yan, S. ShiDu, Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain., J Alzheimers Dis, vol. 51, no. 2, pp. 571-80, 2016.
L. Saarelainen, Taipale, H., Koponen, M., Tanskanen, A., Tolppanen, A. - M., Tiihonen, J., and Hartikainen, S., The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 809-18, 2016.
K. Nakaizumi, Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., and Magata, Y., In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
E. Lehingue, Gueniat, J., Jourdaa, S., Hardouin, J. BenoÎt, Pallardy, A., Courtemanche, H., Rocher, L., Etcharry-Bouyx, F., Auriacombe, S., Mollion, H., Formaglio, M., Rouaud, O., Bretonnière, C., Thomas-Antérion, C., and Boutoleau-Bretonnière, C., Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale., J Alzheimers Dis, vol. 79, no. 4, pp. 1735-1745, 2021.
N. S. Radhakrishnan, Mufti, M., Ortiz, D., Maye, S. T., Melara, J., Lim, D., Rosenberg, E. I., and Price, C. C., Implementing Delirium Prevention in the Era of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 31-36, 2021.